不公平获得新冠肺炎疫苗不能归咎于专利

IF 0.2 4区生物学 Q4 BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Biotechnology Law Report Pub Date : 2022-03-25 DOI:10.1089/blr.2022.29265.us

Raildo Duarte, Hasan Irfan Khan, Alejandro Luna, Ramadan Amin, Charul Yadav, U. Storz

{"title":"不公平获得新冠肺炎疫苗不能归咎于专利","authors":"Raildo Duarte, Hasan Irfan Khan, Alejandro Luna, Ramadan Amin, Charul Yadav, U. Storz","doi":"10.1089/blr.2022.29265.us","DOIUrl":null,"url":null,"abstract":"In view of the inequitable distribution of COVID-19 vaccines, several initiatives have been discussed to waive respective patent rights. This article provides a fact-based multinational study on patent rights protecting BioNTech-Pfizer's vaccine BNT162b2. We conclude that although there actually is a vaccine shortage in many countries, patents cannot be blamed as the scapegoat for said situation.","PeriodicalId":55354,"journal":{"name":"Biotechnology Law Report","volume":"1 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Patents Cannot Be Blamed for Inequitable Access to COVID-19 Vaccines\",\"authors\":\"Raildo Duarte, Hasan Irfan Khan, Alejandro Luna, Ramadan Amin, Charul Yadav, U. Storz\",\"doi\":\"10.1089/blr.2022.29265.us\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In view of the inequitable distribution of COVID-19 vaccines, several initiatives have been discussed to waive respective patent rights. This article provides a fact-based multinational study on patent rights protecting BioNTech-Pfizer's vaccine BNT162b2. We conclude that although there actually is a vaccine shortage in many countries, patents cannot be blamed as the scapegoat for said situation.\",\"PeriodicalId\":55354,\"journal\":{\"name\":\"Biotechnology Law Report\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-03-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biotechnology Law Report\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1089/blr.2022.29265.us\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology Law Report","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1089/blr.2022.29265.us","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}

引用次数: 1

摘要

鉴于新冠肺炎疫苗分配不公平，讨论了放弃各自专利权的几项举措。本文提供了一项基于事实的跨国研究，以保护BioNTech辉瑞公司的疫苗BNT162b2的专利权。我们得出的结论是，尽管许多国家实际上存在疫苗短缺，但专利不能被指责为上述情况的替罪羊。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Patents Cannot Be Blamed for Inequitable Access to COVID-19 Vaccines

In view of the inequitable distribution of COVID-19 vaccines, several initiatives have been discussed to waive respective patent rights. This article provides a fact-based multinational study on patent rights protecting BioNTech-Pfizer's vaccine BNT162b2. We conclude that although there actually is a vaccine shortage in many countries, patents cannot be blamed as the scapegoat for said situation.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Biotechnology Law Report 工程技术-生物工程与应用微生物

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： The leading authoritative journal since 1982 devoted to the evolving body of law and government regulation concerning biotechnology, particularly in the industries in which new products from these technologies are developing the most rapidly: pharmaceuticals, chemicals, agriculture, food processing, energy, mineral recovery, and waste treatment. All legal aspects are rapidly reported, and critical and often hard-to-obtain documents are reproduced.